Trusted in Korea through 5,000 local pharmacies
We believed from the start that topical treatment with diclofenac would be useful in the treatment of PD, for its well-established painkilling and antiinflammatory properties, as well as its free-radical scavenging activity and action against the proinflammatory cytokine cascade, including factor NF-kB production
Research studies have used doses ranging from 10 mcg/kg to several milligrams daily, typically administered once or twice daily
BPC-157 is not approved by Health Canada for human use
Anti-inflammatory nutrition principles align with both endometriosis management and GLP-1 medication support
Cagrilintide + retatrutide swaps semaglutide for retatrutide, which already hits three receptors (GLP-1, GIP, glucagon)